Q4 2023 Holdings
Filed 2024-02-14 | 70 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $487.0M | 16,423,922 | 17.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $215.0M | 1,733,189 | 7.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $210.4M | 14,828,321 | 7.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $120.4M | 6,402,505 | 4.3% |
| Rayzebio Inc | COM | 75525N107 | $115.5M | 1,857,706 | 4.1% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $95.8M | 16,380,327 | 3.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $77.4M | 4,801,540 | 2.8% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $67.7M | 142,500 | 2.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $67.5M | 3,760,690 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $61.8M | 1,444,365 | 2.2% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $60.2M | 5,790,230 | 2.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $58.8M | 1,137,068 | 2.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $54.5M | 3,659,264 | 1.9% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $49.4M | 1,100,466 | 1.8% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $49.3M | 13,169,057 | 1.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $48.8M | 2,696,648 | 1.7% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $46.4M | 1,823,956 | 1.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $41.5M | 3,879,415 | 1.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $41.2M | 977,072 | 1.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $40.1M | 693,200 | 1.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $40.1M | 5,619,914 | 1.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $39.4M | 993,803 | 1.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $38.9M | 1,429,783 | 1.4% |
| Absci Corporation(ABSI) | COM | 00091E109 | $33.7M | 8,031,094 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $33.6M | 3,256,519 | 1.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $33.3M | 935,863 | 1.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $32.6M | 3,865,258 | 1.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $31.2M | 1,374,189 | 1.1% |
| Abbott Labs(ABT) | COM | 002824100 | $29.2M | 265,500 | 1.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $27.6M | 835,537 | 1.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $25.9M | 1,109,476 | 0.9% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $25.4M | 15,328,317 | 0.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $25.0M | 5,503,190 | 0.9% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $24.7M | 2,971,542 | 0.9% |
| Verve Therapeutics Inc | COM | 92539P101 | $24.0M | 1,718,669 | 0.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $24.0M | 95,242 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $22.0M | 1,969,402 | 0.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $20.5M | 86,782 | 0.7% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $19.4M | 1,283,735 | 0.7% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $18.4M | 946,897 | 0.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $18.3M | 54,258 | 0.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $17.9M | 66,100 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $17.1M | 2,914,022 | 0.6% |
| Stryker Corporation(SYK) | COM | 863667101 | $15.9M | 53,141 | 0.6% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $15.7M | 2,148,748 | 0.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $13.8M | 2,625,506 | 0.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $13.7M | 50,082 | 0.5% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $12.0M | 5,872,605 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $11.7M | 1,324,350 | 0.4% |
| Elevance Health Inc(ELV) | COM | 036752103 | $10.9M | 23,079 | 0.4% |